![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CDCA7 |
Gene summary for CDCA7 |
![]() |
Gene information | Species | Human | Gene symbol | CDCA7 | Gene ID | 83879 |
Gene name | cell division cycle associated 7 | |
Gene Alias | ICF3 | |
Cytomap | 2q31.1 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | Q9BWT1 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
83879 | CDCA7 | HTA11_866_2000001011 | Human | Colorectum | AD | 2.45e-04 | -2.34e-01 | -0.1001 |
83879 | CDCA7 | HTA11_866_3004761011 | Human | Colorectum | AD | 1.06e-02 | 3.85e-01 | 0.096 |
83879 | CDCA7 | HTA11_6801_2000001011 | Human | Colorectum | SER | 1.27e-02 | 6.75e-01 | 0.0171 |
83879 | CDCA7 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 9.06e-15 | 8.11e-01 | 0.294 |
83879 | CDCA7 | HTA11_99999965104_69814 | Human | Colorectum | MSS | 6.65e-13 | 9.29e-01 | 0.281 |
83879 | CDCA7 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 2.43e-13 | 8.14e-01 | 0.3859 |
83879 | CDCA7 | F007 | Human | Colorectum | FAP | 4.53e-02 | -2.10e-01 | 0.1176 |
83879 | CDCA7 | A015-C-203 | Human | Colorectum | FAP | 3.77e-12 | -1.83e-01 | -0.1294 |
83879 | CDCA7 | A002-C-201 | Human | Colorectum | FAP | 2.60e-08 | -2.88e-01 | 0.0324 |
83879 | CDCA7 | A001-C-108 | Human | Colorectum | FAP | 2.13e-07 | -1.77e-02 | -0.0272 |
83879 | CDCA7 | A002-C-205 | Human | Colorectum | FAP | 3.14e-06 | -1.38e-01 | -0.1236 |
83879 | CDCA7 | A015-C-006 | Human | Colorectum | FAP | 1.19e-03 | -6.92e-02 | -0.0994 |
83879 | CDCA7 | A002-C-114 | Human | Colorectum | FAP | 5.62e-07 | -2.57e-01 | -0.1561 |
83879 | CDCA7 | A015-C-104 | Human | Colorectum | FAP | 3.15e-14 | -1.35e-01 | -0.1899 |
83879 | CDCA7 | A001-C-014 | Human | Colorectum | FAP | 1.59e-08 | -1.70e-01 | 0.0135 |
83879 | CDCA7 | A002-C-016 | Human | Colorectum | FAP | 7.04e-11 | -2.60e-01 | 0.0521 |
83879 | CDCA7 | A015-C-002 | Human | Colorectum | FAP | 3.78e-02 | -3.31e-02 | -0.0763 |
83879 | CDCA7 | A001-C-203 | Human | Colorectum | FAP | 3.24e-05 | -1.10e-01 | -0.0481 |
83879 | CDCA7 | A002-C-116 | Human | Colorectum | FAP | 4.01e-15 | -2.64e-01 | -0.0452 |
83879 | CDCA7 | A014-C-008 | Human | Colorectum | FAP | 3.08e-04 | -1.81e-01 | -0.191 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CDCA7 | SNV | Missense_Mutation | rs748528043 | c.1142N>A | p.Arg381Gln | p.R381Q | Q9BWT1 | protein_coding | deleterious(0) | probably_damaging(0.992) | TCGA-EY-A1G8-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CDCA7 | deletion | Frame_Shift_Del | novel | c.196delT | p.Tyr66MetfsTer21 | p.Y66Mfs*21 | Q9BWT1 | protein_coding | TCGA-SL-A6JA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
CDCA7 | SNV | Missense_Mutation | rs771816691 | c.304G>A | p.Glu102Lys | p.E102K | Q9BWT1 | protein_coding | tolerated(0.11) | possibly_damaging(0.864) | TCGA-BC-A216-01 | Liver | liver hepatocellular carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
CDCA7 | SNV | Missense_Mutation | c.328N>T | p.Asp110Tyr | p.D110Y | Q9BWT1 | protein_coding | deleterious(0) | possibly_damaging(0.903) | TCGA-DD-A73C-01 | Liver | liver hepatocellular carcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD | |
CDCA7 | SNV | Missense_Mutation | c.1159N>A | p.Glu387Lys | p.E387K | Q9BWT1 | protein_coding | deleterious(0) | possibly_damaging(0.7) | TCGA-FV-A3I0-01 | Liver | liver hepatocellular carcinoma | Female | >=65 | I/II | Chemotherapy | gemcitabine | PD | |
CDCA7 | SNV | Missense_Mutation | c.730C>T | p.Pro244Ser | p.P244S | Q9BWT1 | protein_coding | tolerated(0.47) | benign(0.19) | TCGA-50-6595-01 | Lung | lung adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | carboplatin | PD | |
CDCA7 | SNV | Missense_Mutation | c.613A>C | p.Lys205Gln | p.K205Q | Q9BWT1 | protein_coding | deleterious(0.05) | possibly_damaging(0.833) | TCGA-91-6829-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
CDCA7 | SNV | Missense_Mutation | novel | c.1115G>T | p.Arg372Leu | p.R372L | Q9BWT1 | protein_coding | deleterious(0) | probably_damaging(0.985) | TCGA-33-AASD-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
CDCA7 | SNV | Missense_Mutation | novel | c.707N>T | p.Arg236Met | p.R236M | Q9BWT1 | protein_coding | deleterious(0) | possibly_damaging(0.774) | TCGA-34-2604-01 | Lung | lung squamous cell carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CDCA7 | SNV | Missense_Mutation | novel | c.106N>T | p.Asp36Tyr | p.D36Y | Q9BWT1 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-43-5670-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Chemotherapy | taxotere | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |